Retatrutide activates three receptors (GLP-1, GIP, and glucagon) compared to semaglutide's single GLP-1 target and tirzepatide's dual GLP-1/GIP mechanism
BPC-157 and TB-500 are speculative for structural repair
Subsequent studies were conducted to define the mechanism of DMF-mediated CBS induction through changes in DNA methylation
Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells
MAPK14/p38-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation
The randomized, double-blind, placebo-controlled trial assessed the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of once-daily dosing of TERN-601, showing promising results for this small-molecule treatment